Home / News / New reporting obligation for supply shortages of prescription...

New reporting obligation for supply shortages of prescription medicines

16/04/2020

Since 1 April 2020, if prescription drugs are not available or only available in limited quantities, marketing authorisation holders have had to notify the BASG. Since the new regulation came into force, over 30 medicines have already been included in the BASG's register of marketing restrictions - most of them based on a notification by the marketing authorisation holder, but some also on the initiative of the BASG. These drugs are subject to a temporary export ban. Failure to comply with this ban may result in sanctions.

The complete article is available in German.

COVID-19 Kontakt

Related people

Gabriela-Staber-CMS-AT
Gabriela Staber
Partner
Vienna
Picture of Ruth Mahfoozpour
Ruth Mahfoozpour
Associate
Vienna